46008.1 IP-LS

Résumé

Optimizing Discovery of Small Protein-Based Therapeutics (SPBTs)

Textes supplémentaires

Abstract

Small protein-based therapeutics (SPBTs) are an emerging drug class. Through its unique SPBT discovery platform, Orion has a key competitive advantage in this field. In this project UNIGE and Orion will develop new technology to improve the platform in three key areas: speed, robustness and scope.

Participants

Jarret Engstrom

Wirtschaftspartner

Orion Biotechnology Holding SA CHE-318.471.257 Jarret Engstrom c/o ORION Biotechnology Switzerland Sàrl, avenue de Sécheron 15 1202 Genève GE CH

Oliver Hartley

Kontaktperson

Oliver.Hartley@unige.ch

Université de Genève Oliver Hartley Rue Michel Servet 1 1211 Genève GE CH

Détails du projet

Office de recherche: INNOSUISSE
Statut du projet: Abgeschlossen
Type de projet: Forschungsprojekt
Date de début: 2020-12-31
Date de fin: 2022-12-31
Coûts totaux approuvés: CHF 923900.58
Section: 60 Life Sciences
Domaine politique NABS: Industrielle Produktivität und Technologie

Disciplines de recherche

T410 Pharmaceuticals and related technologies 100.0%